The vasodilator 17,18-epoxyeicosatetraenoic acid targets the pore-forming BK α channel subunit in rodents

Experimental Physiology

Volumn 92, Issue 6, 2007, Pages 1067-1076

  Hercule, Hantz C ^a   Salanova, Birgit ^a   Essin, Kirill ^a,b   Honeck, Horst ^c   Falck, John R ^d   Sausbier, Matthias ^e   Ruth, Peter ^e   Schunck, Wolf Hagen ^c   Luft, Friedrich C ^a   Gollasch, Maik ^b  

^a FRANZ VOLHARD CLINIC   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 17,18 EPOXYEICOSATETRAENOIC ACID; ARACHIDONIC ACID DERIVATIVE; CALCIUM; CALCIUM CHANNEL; EPOXYICOSATRIENOIC ACID; POTASSIUM CHANNEL; RYANODINE; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY; CALCIUM TRANSPORT; CELL ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PROTEIN FUNCTION; RAT; RODENT; SARCOPLASMIC RETICULUM; SENSITIVITY ANALYSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASODILATATION; WHOLE CELL;

EID: 35248841452     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.038166     Document Type: Article

References (38)

1. Barbosa-Sicard E, Markovic M, Honeck H, Christ B, Muller DN & Schunck WH (2005). Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. Biochem Biophys Res Commun 329, 1275 1281.
2. Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT & Aldrich RW (2000). Vasoregulation by the β1 subunit of the calcium-activated potassium channel. Nature 407, 870 876.
3. Bychkov R, Gollasch M, Steinke T, Ried C, Luft FC & Haller H (1998). Calcium-activated potassium channels and nitrate-induced vasodilation in human coronary arteries. J Pharmacol Exp Ther 285, 293 298.
4. Campbell WB & Harder DR (1999). Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res 84, 484 488.
5. Connor WE (2000). Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71, 171S 175S.
6. 3 cells. Am J Physiol Cell Physiol 279, C1211 C1219.
7. Ellis EF, Police RJ, Yancey L, McKinney JS & Amruthesh SC (1990). Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol Heart Circ Physiol 259, H1171 H1177.
8. Engler MB, Engler MM, Browne A, Sun YP & Sievers R (2000). Mechanisms of vasorelaxation induced by eicosapentaenoic acid (20:5n-3) in WKY rat aorta. Br J Pharmacol 131, 1793 1799.
9. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I & Busse R (1999). Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401, 493 497.
10. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck JR & Campbell WB (2002). 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 90, 1028 1036.
11. + currents in human coronary artery vascular smooth muscle cells. Circ Res 78, 676 688.
12. 2+ sparks as elementary physiological events. Circ Res 83, 1104 1114.
13. 2+ currents in intestinal and vascular smooth muscle. Br J Pharmacol 149, 155 162.
14. Imig JD (2006). Eicosanoids and renal vascular function in diseases. Clin Sci (Lond) 111, 21 34.
15. Lauterbach B, Barbosa-Sicard E, Wang MH, Honeck H, Kargel E, Theuer J, Schwartzman ML, Haller H, Luft FC, Gollasch M & Schunck WH (2002). Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators. Hypertension 39, 609 613.
16. Lawson DL, Mehta JL, Saldeen K, Mehta P & Saldeen TG (1991). Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids 4, 217 223.
17. Li PL, Zhang DX, Ge ZD & Campbell WB (2002). Role of ADP-ribose in 11,12-EET-induced activation of K(Ca) channels in coronary arterial smooth muscle cells. Am J Physiol Heart Circ Physiol 282, H1229 H1236.
18. Lohn M, Jessner W, Furstenau M, Wellner M, Sorrentino V, Haller H, Luft FC & Gollasch M (2001a). Regulation of calcium sparks and spontaneous transient outward currents by RyR3 in arterial vascular smooth muscle cells. Circ Res 89, 1051 1057.
19. 2+] and diameter in mouse cerebral arteries. J Appl Physiol 91, 1350 1354.
20. 2+ channels in hippocampal neurons. Nature 395, 900 905.
21. Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H & Seino S (2002). Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8, 466 472.
22. Muller DN, Schmidt C, Barbosa-Sicard E, Wellner M, Gross V, Hercule H, Markovic M, Honeck H, Luft FC & Schunck WH (2006). Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation. Biochem J 403, 109 118.
23. + channels. Cardiovasc Drugs Ther 7 (Suppl. 3 605 610.
24. Nguyen X, Wang MH, Reddy KM, Falck JR & Schwartzman ML (1999). Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am J Physiol Regul Integr Comp Physiol 276, R1691 R1700.
25. Nyby MD, Matsumoto K, Yamamoto K, Abedi K, Eslami P, Hernandez G, Smutko V, Berger ME & Tuck ML (2005). Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats. Am J Hypertens 18, 213 219.
26. 2+-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett 487, 361 366.
27. 2+ spark/STOC coupling and elevated blood pressure. Circ Res 87, E53 E60.
28. Quilley J & McGiff JC (2000). Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol Sci 21, 121 124.
29. Roman RJ (2002). P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82, 131 185.
30. Roman RJ, Maier KG, Sun CW, Harder DR & Alonso-Galicia M (2000). Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids. Clin Exp Pharmacol Physiol 27, 855 865.
31. Sausbier M, Arntz C, Bucurenciu I, Zhao H, Zhou XB, Sausbier U, Feil S, Kamm S, Essin K, Sailer CA, Abdullah U, Krippeit-Drews P, Feil R, Hofmann F, Knaus HG, Kenyon C, Shipston MJ, Storm JF, Neuhuber W, Korth M, Schubert R, Gollasch M & Ruth P (2005). Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice. Circulation 112, 60 68.
32. Simopoulos AP (2003). Essential fatty acids in health and chronic diseases. Forum Nutr 56, 67 70.
33. Spector AA & Norris AW (2006). Action of epoxyeicosatrienoic acids (EETs) on cellular function. Acta Physiol Scand 164, 549 557.
34. + channel modulation in arterial smooth muscle. Acta Physiol Scand 164, 549 557.
35. Ye D, Zhang D, Oltman C, Dellsperger K, Lee HC & VanRollins M (2002). Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. J Pharmacol Exp Ther 303, 768 776.
36. Ye D, Zhou W & Lee HC (2005). Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid. Am J Physiol Heart Circ Physiol 288, H358 H364.
37. Zeldin DC (2001). Epoxygenase pathways of arachidonic acid metabolism. J Biol Chem 276, 36059 36062.
38. Ca channels. Am J Physiol Heart Circ Physiol 280, H2430 H2440.